Connection
David Camidge to Ipilimumab
This is a "connection" page, showing publications David Camidge has written about Ipilimumab.
|
|
Connection Strength |
|
|
|
|
|
0.045 |
|
|
|
-
Ready NE, Ott PA, Hellmann MD, Zugazagoitia J, Hann CL, de Braud F, Antonia SJ, Ascierto PA, Moreno V, Atmaca A, Salvagni S, Taylor M, Amin A, Camidge DR, Horn L, Calvo E, Li A, Lin WH, Callahan MK, Spigel DR. Nivolumab Monotherapy and Nivolumab Plus Ipilimumab in Recurrent Small Cell Lung Cancer: Results From the CheckMate 032 Randomized Cohort. J Thorac Oncol. 2020 03; 15(3):426-435.
Score: 0.045